- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 147.73M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $668.1M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $667.77M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $200.05M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $198.46M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $73.71M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $62.49M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.19B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.26B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $385.44M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $394.02M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.41B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.42B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 145.33M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $14.28M |
| Capex | Q1 2025 · Mar 31, 2024 | $1.55M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $2.79M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.05B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.15B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.57 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.57 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $13.46M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$82.56M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$74.86M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $20.7M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $38.34M |
| Revenue | Q1 2025 · Mar 31, 2024 | $59.04M |